MOLECULAR SIGNATURE AND ITS USES AS DIAGNOSTIC AGENT
摘要
<p>The present invention relates to a method for determining a peripheral T-cell lymphoma (PTCL), in particular for subtyping PTCLs with a clinically significant diagnostic accuracy, said method being based on the use of a molecular signature. Furthermore, the present invention relates to said molecular signature and its use as a diagnostic agent.</p>
